Table 2.
Tobacco-related characteristics for the total sample and by the group at baseline.
| Substance usea | Nb (%) | |||||||||
|
|
Total | CGEc | CGRd | CLEe | CLRf | SGEg | SGRh | SLEi | SLRj | |
| Cigarettes |
|
|
|
|
|
|
|
|
|
|
|
|
Ever | 287 (45.1) | 37 (45.7) | 34 (44.2) | 28 (38.4) | 35 (43.2) | 43 (50.0) | 41 (51.9) | 35 (45.5) | 34 (41.5) |
|
|
p30k | 87 (13.7) | 12 (14.8) | 7 (9.1) | 9 (12.3) | 14 (17.3) | 11 (12.8) | 11 (13.9) | 12 (15.6) | 11 (13.4) |
| Cigars |
|
|
|
|
|
|
|
|
|
|
|
|
Ever | 206 (32.4) | 27 (33.3) | 29 (37.7) | 29 (39.7) | 22 (27.2) | 20 (23.3) | 28 (35.4) | 25 (32.5) | 26 (31.7) |
|
|
p30 | 61 (9.6) | 2 (7.4) | 11 (14.3) | 4 (5.5) | 9 (11.1) | 8 (9.3) | 10 (12.7) | 4 (5.2) | 9 (11.0) |
| Smokeless |
|
|
|
|
|
|
|
|
|
|
|
|
Ever | 33 (5.2) | 2 (2.5) | 1 (1.3) | 6 (8.2) | 3 (3.7) | 2 (2.3) | 9 (11.4) | 6 (7.8) | 4 (4.9) |
|
|
p30 | 5 (0.8) | 1 (1.2) | 1 (1.3) | 1 (1.4) | 0 (0.0) | 0 (0.0) | 2 (2.5) | 0 (0.0) | 0 (0.0) |
| Hookah |
|
|
|
|
|
|
|
|
|
|
|
|
Ever | 354 (55.7) | 42 (51.9) | 43 (55.8) | 34 (46.6) | 46 (56.8) | 52 (60.5) | 46 (58.2) | 44 (57.1) | 47 (57.3) |
|
|
p30 | 116 (18.2) | 16 (19.8) | 15 (19.5) | 8 (11.0) | 15 (18.5) | 18 (20.9) | 15 (19.0) | 15 (19.5) | 14 (17.1) |
| e-Cigarettes |
|
|
|
|
|
|
|
|
|
|
|
|
Ever | 171 (26.9) | 22 (27.2) | 19 (24.7) | 19 (26.0) | 21 (25.9) | 26 (30.2) | 22 (27.9) | 20 (26.0) | 22 (26.8) |
|
|
p30 | 50 (7.9) | 5 (6.2) | 5 (6.5) | 7 (9.6) | 7 (8.6) | 13 (15.1) | 5 (6.3) | 6 (7.8) | 2 (2.4) |
| Marijuana | 161 (25.3) | 21 (25.9) | 24 (31.2) | 15 (20.6) | 21 (25.9) | 22 (25.6) | 24 (30.4) | 17 (22.1) | 17 (20.7) | |
| Poly-tobacco usek | 300 (47.2) | 43 (53.1) | 34 (44.2) | 35 (48.0) | 39 (48.2) | 40 (46.5) | 42 (53.2) | 34 (44.2) | 33 (40.2) | |
| Susceptibility to usel |
|
|
|
|
|
|
|
|
|
|
|
|
Cigarettes | 46 (13.2) | 7 (15.9) | 2 (4.7) | 2 (4.4) | 9 (19.6) | 7 (18.3) | 6 (15.8) | 4 (9.5) | 9 (18.8) |
|
|
Cigars | 96 (22.7) | 14 (24.1) | 4 (7.8) | 7 (14.9) | 19 (29.2) | 18 (26.1) | 10 (16.7) | 10 (18.2) | 14 (23.7) |
|
|
Smokeless | 80 (13.3) | 14 (17.7) | 5 (6.6) | 7 (10.5) | 13 (16.7) | 10 (11.9) | 8 (11.4) | 10 (14.1) | 13 (16.7) |
|
|
Hookah | 85 (30.1) | 19 (48.7) | 6 (17.7) | 12 (30.8) | 10 (28.6) | 11 (32.4) | 8 (24.2) | 6 (18.2) | 13 (37.1) |
|
|
e-Cigarettes | 125 (26.9) | 21 (35.59) | 13 (22.4) | 11 (20.4) | 16 (26.7) | 13 (21.7) | 18 (31.6) | 14 (24.6) | 19 (31.7) |
| Use marijuana and tobacco | 275 (43.2) | 40 (49.4) | 39 (50.6) | 26 (35.6) | 34 (42) | 38 (43.7) | 32 (40.5) | 31 (40.3) | 35 (42.7) | |
| Secondhand smoke in house | 68 (10.7) | 10 (12.3) | 9 (11.7) | 10 (13.7) | 7 (8.6) | 6 (6.9) | 4 (5.1) | 12 (15.6) | 10 (12.2) | |
| Have friends who use tobacco | 566 (89.0) | 76 (93.8) | 67 (87.0) | 60 (82.2) | 68 (84.0) | 80 (92.0) | 69 (87.3) | 72 (93.5) | 74 (90.2) | |
aResults that include Ever product use followed by Past 30 days use (p30).
bRandomization of participants to 8 groups of short message service text messages.
cCGE: complex, gain-framed, emotional.
dCGR: complex, gain-framed, rational.
eCLE: complex, loss-framed, emotional.
fCLR: complex, loss-framed, rational.
gSGE: simple, gain-framed, emotional.
hSGR: simple, gain-framed, rational.
iSLE: simple, loss-framed, emotional.
jSLR: simple, loss-framed, rational.
kRefers to the concurrent use of multiple tobacco products among participants at any time.
lSusceptibility to use is measured with nonusers only.